geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis


, : Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet (North American Edition) 352(9139): 1491-1497, Nov 7

Background. The beneficial effects of interferon beta have only been shown for patients in the relapsing-remitting phase of multiple sclerosis (MS). The role of interferon beta in the treatment of patients who are in the secondary progressive phase of the disease (SP-MS), and for whom no effective drug treatment is available, has not been assessed. Methods. In this multicentre, double-masked, randomised, placebo-controlled trial, outpatients with SP-MS having scores of 3.0-6.5 on the Expanded Disability Status Scale (EDSS) received either 8 million IU interferon beta-1b every other day subcutaneously, or placebo, for up to 3 years. The primary outcome was the time to confirmed progression in disability as measured by a 1.0 point increase on the EDSS, sustained for at least 3 months, or a 0-5 point increase if the baseline EDSS was 6.0 or 6.5. A prospectively planned interim analysis of safety and efficacy of the intention-to-treat population was done after all patients had been in the study for at least 2 years. Findings. 358 patients with SP-MS were allocated placebo and 360 were allocated interferon beta-1b; 57 patients (31 placebo, 26 interferon beta-1b) were lost to follow-up. There was a highly significant difference in time to confirmed progression of disability in favour of interferon beta-1b (P=0.0008). Interferon beta-1b delayed progression for 9-12 months in a study period of 2-3 years. The odds ratio for confirmed progression was 0.65 (95% CI 0-52-0-83). This beneficial effect was seen in patients with superimposed relapses and in patients who had only progressive deterioration without relapses. Positive results were also obtained regarding time to becoming wheelchair-bound, relapse rate and severity, number of steroid treatments and hospital admissions, as well as on magnetic resonance imaging variables. The drug was safe and side effects were in line with previous experience with interferon beta-1b. The study was stopped after the interim results gave clear evidence of efficacy. Interpretation. Treatment with interferon beta-1b delays sustained neurological deterioration in patients with SPMS. interferon beta-1b is the first treatment to show a therapeutic effect in patients with SP-MS.

US$29.90


Other references

Herrmann, D., 1966: Permanent combined plastic-wire splinting in advanced periodontitis marginalis profunda. Zahnarztliche Rundschau 75(1): 36-39

Arnold, ML.; Honeycutt, RL.; Baker, RJ.; Sarich, VM.; Knox Jones, J.; Jr., 1982: Resolving a phylogeny with multiple data sets: a systematic study of phyllostomoid bats. Occasional Papers Museum of Texas Tech University, 1-15 No. 77

Tell, E.; Rohrle, M., 1979: Evaluation of florentines on the basis of chemical and sensory tests. 282 florentine biscuits were analysed for fat composition. In general, those made from industrially prepared caramel masses contained 0-10% milk fat (of total fat) and those prepared entirely 'in house' by confectioners contained 20-100%...

Liu, T.; Ghafoori, P.; Gobburu, J.V.S., 2016: Allometry Is a Reasonable Choice in Pediatric Drug Development. NlmCategory="UNASSIGNED">Pharmacokinetics (PK) plays a key role in bridging drug efficacy and safety from adults to pediatric patients. The principal purpose of projecting dosing in pediatrics is to guide trial design, not to waive th...

Gausserès, N.; Mahè, S.; Benamouzig, R.; Luengo, C.; Drouet, H.; Rautureau, J.; Tomè, D., 1996: The gastro-ileal digestion of 15N-labelled pea nitrogen in adult humans. The aim of the present study was to determine the gastro-ileal behaviour of pea protein in humans. For this purpose, twelve healthy volunteers were intubated with an intestinal tube located either in the jejunum (n 5) or in the ileum (n 7). After...

Brembilla-Perrot, B.; Houriez, P.; Claudon, O.; Beurrier, D.; Preiss, J.P.; Terrier Chaise, A.; Louis, P., 2000: Reproducibility of response to programmed atrial stimulation. The induction of atrial tachyarrhythmias (ATAs) is used to guide the medical or ablative treatment of these tachycardias. To date no information is available regarding the reproducibility of programmed atrial stimulation (PAS) induced ATA. The pur...

McCarthy, J.C.; Lee, J-Ann., 2002: Acetabular dysplasia: a paradigm of arthroscopic examination of chondral injuries. The current authors show the value of arthroscopy in diagnosing labral and acetabular cartilage injury and examining the relationship between those injuries and acetabular dysplasia. Between 1989 and 2000, 170 hips in 163 patients with mild acetab...

Altman, Amnon, 2002: Current Directions in Autoimmunity Signal transduction pathways in autoimmunity. The chapters in this book demonstrate the close link between aberrant signaling pathways and autoimmune diseases. They cover a variety of cells, receptors and intracellular signaling molecules in the immune system. It is written for clinical inves...

Scott, W.B., 1937: A Remarkable Sabretooth-Like Creodont From The Eocene Of Utah. The water potential of leaves in situ can be measured without temperature control with a miniature, single-junction psychrometer constructed from silver foil and attached to the leaf with a silver-impregnated, conductive coating. The temperature o...

Millette, M.; Mok, E.; Legault, L., 2014: Impact of elective hospital admissions on glycaemic control in adolescents with poorly controlled type 1 diabetes. Different treatment strategies have been used to manage adolescents with poorly controlled type 1 diabetes. We investigated whether a brief elective hospital admission improves haemoglobin A<inf loc="post">1c</inf> (HbA<in...